299 related articles for article (PubMed ID: 31660973)
41. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.
Nishida N; Nagasaka T; Nishimura T; Ikai I; Boland CR; Goel A
Hepatology; 2008 Mar; 47(3):908-18. PubMed ID: 18161048
[TBL] [Abstract][Full Text] [Related]
42. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma.
Feitelson MA
Cancer Lett; 2006 Jul; 239(1):10-20. PubMed ID: 16154256
[TBL] [Abstract][Full Text] [Related]
43. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
Zhang QX; Li SL; Yao YQ; Li TJ
Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
[TBL] [Abstract][Full Text] [Related]
44. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.
Arzumanyan A; Reis HM; Feitelson MA
Nat Rev Cancer; 2013 Feb; 13(2):123-35. PubMed ID: 23344543
[TBL] [Abstract][Full Text] [Related]
45. Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma.
Lee CF; Ling ZQ; Zhao T; Lee KR
World J Gastroenterol; 2008 Oct; 14(39):6072-7. PubMed ID: 18932288
[TBL] [Abstract][Full Text] [Related]
46. Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations.
Raptis I; Koskinas J; Emmanouil T; Hadziyannis S
J Viral Hepat; 2003 Nov; 10(6):450-4. PubMed ID: 14633179
[TBL] [Abstract][Full Text] [Related]
47. Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).
Bréchot C; Gozuacik D; Murakami Y; Paterlini-Bréchot P
Semin Cancer Biol; 2000 Jun; 10(3):211-31. PubMed ID: 10936070
[TBL] [Abstract][Full Text] [Related]
48. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
49. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
50. Impact of hepatitis virus and aging on DNA methylation in human hepatocarcinogenesis.
Nishida N
Histol Histopathol; 2010 May; 25(5):647-54. PubMed ID: 20238302
[TBL] [Abstract][Full Text] [Related]
51. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
[TBL] [Abstract][Full Text] [Related]
52. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
Lok AS
J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
[TBL] [Abstract][Full Text] [Related]
53. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y; Tani M; Kurata T; Abe K
Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
[TBL] [Abstract][Full Text] [Related]
54. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma.
Yang JD; Kim WR; Coelho R; Mettler TA; Benson JT; Sanderson SO; Therneau TM; Kim B; Roberts LR
Clin Gastroenterol Hepatol; 2011 Jan; 9(1):64-70. PubMed ID: 20831903
[TBL] [Abstract][Full Text] [Related]
55. 'Liver let die': oxidative DNA damage and hepatotropic viruses.
Higgs MR; Chouteau P; Lerat H
J Gen Virol; 2014 May; 95(Pt 5):991-1004. PubMed ID: 24496828
[TBL] [Abstract][Full Text] [Related]
56. DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.
Zheng Y; Hlady RA; Joyce BT; Robertson KD; He C; Nannini DR; Kibbe WA; Achenbach CJ; Murphy RL; Roberts LR; Hou L
Clin Epigenetics; 2019 Oct; 11(1):145. PubMed ID: 31639042
[TBL] [Abstract][Full Text] [Related]
57. Serial analysis of gene expression in chronic hepatitis C and hepatocellular carcinoma.
Yamashita T; Kaneko S; Hashimoto S; Sato T; Nagai S; Toyoda N; Suzuki T; Kobayashi K; Matsushima K
Biochem Biophys Res Commun; 2001 Mar; 282(2):647-54. PubMed ID: 11401510
[TBL] [Abstract][Full Text] [Related]
58. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
59. Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C virus infected HCC.
Yuan W; Huang T; Yu J; Zeng L; Lian B; He Q; Li Y; Zhang X; Zhou F; Xie L
Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):271-9. PubMed ID: 23774196
[TBL] [Abstract][Full Text] [Related]
60. Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis.
Rongrui L; Na H; Zongfang L; Fanpu J; Shiwen J
Curr Pharm Des; 2014; 20(11):1715-25. PubMed ID: 23888939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]